About Antibody Analytics
Antibody Analytics is a company based in Lanark (United Kingdom) founded in 2015. Antibody Analytics offers products and services including Drug Development Services, Assays, and Equipment Services. Antibody Analytics operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
- Headquarter Lanark, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Antibody Analytics Limited
- Date of Incorporation 24 Nov, 2015
- Jurisdiction MOTHERWELL, NORTH LANARKSHIRE, SCOTLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antibody Analytics
Antibody Analytics offers a comprehensive portfolio of products and services, including Drug Development Services, Assays, and Equipment Services.
Offers immunology assays and testing for therapeutic development phases.
Provides innovative assays for precise drug discovery and evaluation.
Delivers state-of-the-art equipment for reliable scientific data generation.
People of Antibody Analytics
Unlock access to complete
Funding Insights of Antibody Analytics
Investors in Antibody Analytics
Antibody Analytics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NorthEdge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NorthEdge is recognized as a regional private equity firm.
|
Locked | Locked | Locked |
Investor details for Antibody Analytics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Antibody Analytics
Investment portfolio details for Antibody Analytics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Antibody Analytics
Detailed financials for Antibody Analytics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Antibody Analytics Comparisons
Peer comparison for Antibody Analytics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Antibody Analytics
Antibody Analytics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| Locked | Locked | Locked |
Cardiac safety testing is conducted using iPS-derived heart cells.
|
|
| Locked | Locked | Locked |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| Locked | Locked | Locked |
Developer of transformational medicines for neurological disorders
|
|
| Locked | Locked | Locked |
Cell-based solutions are provided to accelerate therapy discovery and development.
|
|
| Locked | Locked | Locked |
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
|
Detailed competitors of Antibody Analytics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Antibody Analytics
Complete news archive for Antibody Analytics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antibody Analytics
Antibody Analytics was founded in 2015 and raised its 1st funding round 8 years after it was founded.
Antibody Analytics is headquartered in Lanark, United Kingdom. It is registered at Lanark, South Lanarkshire, United Kingdom.
Antibody Analytics was founded in 2015 and is based in Lanark, United Kingdom. Operations focus on the biotechnology sector, where antibody characterization assays are conducted, including ADCC, CDC, and ADCP evaluations. Assays for T cell engagers and investigatory biosimilar assays are performed. Custom assay development is also undertaken to support client needs in antibody-related research.
Antibody Analytics's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
Antibody Analytics offers Drug Development Services, Assays, and Equipment Services.
Antibody Analytics has 1 investor. Key investors include NorthEdge.